ACROMETA clinches record $31 million contract for semiconductor industry

– Document contract gain considering that listing in 2016 sites Team on bigger platform
– Deal from renowned Customer in semicon business riding expansion wave
– Nicely positioned for publish-COVID lately finished R&D/production lab for COVID-19

SINGAPORE, Apr 22, 2022 – (ACN Newswire) – Catalist-shown AcroMeta Team Constrained (ACROMETA SGX: 43F), these days announced that its wholly owned subsidiary AcroMec Engineers Pte Ltd (ACROMEC) has won a $31 million deal for the in shape-out of an additional floor within just the current built-in sophisticated manufacturing facility in Singapore of a foremost large-tech purchaser. When accomplished in 2023, the expansion will considerably enhance its manufacturing ability.

ACROMEC’s specialties in controlled ecosystem engineering

The means to succinctly and precisely manage bodily variables this kind of as temperature, air purity, humidity, and pressure in facility, like the product or service production space is a mission significant prerequisite. ACROMEC is completely ready to consider on this job with the requisite monitor report, owning completed numerous assignments in clear rooms, laboratories and state-of-the-art manufacturing services.

Completion of previously introduced task for Nasdaq-outlined Genscript Biotech’s Singapore R&D and production facility

ACROMEC’S robust monitor report is also viewed getting, before on, effectively completed the prestigious contract for the structure and development of Genscript’s R&D and manufacturing laboratory amenities where by they are utilised for the manufacture of the first-in-earth C-Go Serological Examination Kit by the Duke University-NUS Health care University collaboration. C-Move is a sport-modifying blood screening kit that establish a person’s degree of immunity against COVID-19 following vaccination.

Solid outlook for ACROMETA’s managed environment engineering company

ACROMETA Co-Founder, Chairman and CEO Lim Say Chin is heartened by the sizeable deal acquire. It displays nicely on the substantial stage of self-assurance that our Buyer has on us. He said, “We are optimistic on the development of our controlled surroundings enterprise. Our organization is well positioned for the Post-COVID planet. We are possessing much more clients investing in setting up facilities yet again for the long term, both equally to get ready for the subsequent pandemic and to prepare for technological expansion. In fact, we see things to do creating up in the biotechnology and semiconductor sectors, and we are happy to serve this room.”

The deal is predicted to commence shortly and will materially add positively to the earnings for every share and net tangible belongings for every share of the Team for the money 12 months ending 30 September 2022.

SGXNET Reference: https://tinyurl.com/SGX-43F-20220422

About AcroMeta Team Minimal [SGX: 43F] [RIC: ACRI.SI] [BB: ACRO.SP]

AcroMeta Team Minimal (previously AcroMec Constrained) is an proven specialist engineering services service provider with a lot more than 20 many years of experience in the industry of controlled environments. The Team has in excess of the years acquired expertise in the design and development of amenities requiring controlled environments such as laboratories, healthcare and sterile facilities and cleanrooms.

ACROMETA’s business is divided into two main segments: (i) Engineering, procurement, and construction solutions, specialising in architectural, and mechanical, electrical and system is effective inside of managed environments and (ii) Servicing and repair services of amenities and equipment of controlled environments and their supporting infrastructure.

The Group primarily serves the healthcare, biotechnology, pharmaceutical, study and academia, and electronics sectors. ACROMETA counts among its buyers, hospitals and health-related centres, govt businesses, investigation and growth businesses or organizations, investigate and enhancement units of multinational firms, tertiary educational institutions, pharmaceutical firms, semiconductor production businesses, and multinational engineering firms.

The organization has been detailed on the Catalist board of the SGX considering the fact that 2016, and grew to become AcroMeta Team Confined (earlier AcroMec Restricted) on February 18, 2022. For additional information, remember to go to www.acrometa.com.

Media and Analysts Call:
ACROMETA Team Constrained
Mr Jerry Tan
Chief Fiscal Officer
Tel: +65 6415 0574
E mail: [email protected]

Waterbrooks Consultants Pte Ltd
Mr Wayne Koo
Tel: +65 6958 8008 / +65 9338 8166
E-mail: [email protected]
E mail: [email protected]

This media release has been reviewed by the Company’s sponsor, PrimePartners Corporate Finance Pte. Ltd. (the “Sponsor”). It has not been examined or authorised by the Singapore Exchange Securities Investing Constrained (the “Exchange”) and the Trade assumes no accountability for the contents of this doc, which includes the correctness of any of the statements or views produced or stories contained in this document.

The contact person for the Sponsor is Mr. Joseph Au, 16 Collyer Quay, #10-00 Earnings at Raffles, Singapore 049318, [email protected].

Resource: AcroMeta Team Minimal

Copyright 2022 ACN Newswire . All legal rights reserved.